Disseminated Cryptococcus deuterogattii (AFLP6/VGII) infection in an Arabian horse from Dubai. Kinne J, Joseph M, Wernery U, Nogradi N, Hagen F. Molecular characterization and antifungal susceptibility testing of sequentially obtained clinical Cryptococcus deneoformans and Cryptococcus neoformans isolates from Ljubljana.
Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis. Uchida K, Nakata K, Carey B, Chalk C, Suzuki T, Sakagami T, et al. Anti–GM-CSF autoantibodies in patients with cryptococcal meningitis. Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, Angkasekwinai N, et al. Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Sologuren I, Boisson-Dupuis S, Pestano J, Vincent QB, Fernández-Pérez L, Chapgier A, et al. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease. 2010 47(9):635–7.Įsteve-Solé A, Sologuren I, Martínez-Saavedra MT, Deyà-Martínez À, Oleaga-Quintas C, Martinez-Barricarte R, et al. Oesophageal squamous cell carcinoma in a young adult with IL-12R beta 1 deficiency. 2015 305(7):719–23.Ĭárdenes M, Angel-Moreno A, Fieschi C, Sologuren I, Colino E, Molinés A, et al. Cryptococcosis due to Cryptococcus gattii in Germany from 2004–2013. Smith IM, Stephan C, Hogardt M, Klawe C, Tintelnot K, Rickerts V. Autochthonous and dormant Cryptococcus gattii infections in Europe. Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R, Montagna MT, et al. Environmental distribution of Cryptococcus neoformans and C. 2019 129:16–29.Ĭogliati M, D’Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, et al. Genotypes and population genetics of Cryptococcus neoformans and Cryptococcus gattii species complexes in Europe and the Mediterranean area. Ĭogliati M, Desnos-Ollivier M, McCormick-Smith I, Rickerts V, Ferreira-Paim K, Meyer W, et al. 2017 The case for adopting the "species complex" nomenclature for the etiologic agents of cryptococcosis. Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, et al. 2017 Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus. Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionov E, et al. Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest. Smith RM, Mba-Jonas A, Tourdjman M, Schimek T, DeBess E, Marsden-Haug N, Harris JR. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. British Columbia Cryptococcus gattii working group epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Galanis E, MacDougall L, Kidd S, Morshed M. Ecoepidemiology of Cryptococcus gattii in developing countries. Herkert PF, Hagen F, Pinheiro RL, Muro MD, Meis JF, Queiroz-Telles F. Projecting global occurrence of Cryptococcus gattii.